Open Access

Signal Transduction and Targeted Therapy makes all content freely available to all researchers worldwide, ensuring maximum dissemination of content through the platform. Content is published online on a weekly basis to provide timely communication to the community and keep publication times to a minimum.

Publishing open access

Signal Transduction and Targeted Therapy is an open access journal: authors pay an article processing charge (APC) for their accepted articles to be open access online and freely accessible, immediately upon publication, under a Creative Commons license.

To facilitate self-archiving Springer Nature deposits open access articles in PubMed Central and Europe PubMed Central on publication. Authors are also permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication.

Visit our open research site for detailed information about publishing open access in Signal Transduction and Targeted Therapy

Open access at Springer Nature